Breaking News
1. Donald Trump slaps fresh tariffs on 14 nations, 40% on Myanmar and Laos      2. Explosive for Pulwama attack bought via e-commerce platform: Global terror watchdog      3. PM Modi conferred with Brazil's highest civilian award, says ‘moment of immense pride and emotion’      4. Bharat Bandh on 9 July 2025: Over 25 crore workers to go on strike — Are banks, schools, colleges open today?      5. As Trump warns BRICS, China, Russia say group doesn’t target anyone      6. Bharat Bandh: Over 25 crore workers expected to participate, public services likely to be hit on Wednesday      7. Netanyahu nominates Trump for Nobel Peace Prize      8. "Close To Making Deal With India": Trump As He Slaps Tariffs On 14 Countries      9. India will give a ‘new form’ to BRICS grouping in 2026: PM Modi      10. South Korean markets sink as Trump slaps 25% tariff on exports      11. Melania Trump Faces Criticism For Social Media Post On Texas Floods      12. Israel attacks three Yemeni ports and power plant, Israeli military says      13. RJD MP Moves Supreme Court Against Bihar Electoral Roll Revision, Asks Why Aadhaar Card Not Accepted By ECI      14. Trump says alignment with BRICS' 'anti-American policies' to invite additional 10% tariffs      15. Two-thirds of humanity still lack proper representation in 20th century global institutions: PM Modi      16. Kolkata gangrape case: Accused drank alcohol in college for hours after assault; warned guard to stay quiet      17. Supreme Court admin seeks removal of ex-CJI Chandrachud from official residence      18. 'To give you your freedom back': Elon Musk officially launches new political party; names it 'America Party'      19. "I Am A Simple Buddhist Monk": Dalai Lama's 90th Birthday Message      20. "I Am A Simple Buddhist Monk": Dalai Lama's 90th Birthday Message     

AI Chatbots Like ChatGPT Show Promise in Evidence-Based Depression Care

  • Posted on October 18, 2023
  • Technology
  • By Arijit Dutta
  • 400 Views

A groundbreaking study published in the open-access journal Family Medicine and Community Health suggests that ChatGPT, OpenAI's AI chatbot, could surpass primary care doctors in evidence-based depression management. This research delves into the capabilities of ChatGPT, unveiling its potential to provide objective and data-driven insights for clinical depression while sidestepping biases present in doctor-patient relationships.

AI Chatbots Like ChatGPT Show Promise in Evidence-Based Depression Care Image Source -www.siasat.com

A groundbreaking study published in the open-access journal Family Medicine and Community Health suggests that ChatGPT, OpenAI's AI chatbot, could surpass primary care doctors in evidence-based depression management. This research delves into the capabilities of ChatGPT, unveiling its potential to provide objective and data-driven insights for clinical depression while sidestepping biases present in doctor-patient relationships.

The study focused on assessing ChatGPT's ability to recommend treatment approaches for both mild and severe major depression, with a specific eye on biases related to gender and social class. When questioned about primary care physician recommendations, ChatGPT offered a range of suggestions, including "watchful waiting," "referral for psychotherapy," "prescribed drugs for depression, anxiety, or sleep problems," and "referral for psychotherapy combined with prescribed drugs."

In a remarkable revelation, the research found that ChatGPT-3.5 and ChatGPT-4 recommended psychotherapy referral in 95% and 97.5% of cases for mild depression, far exceeding the 4% suggested by family doctors, aligning closely with clinical guidelines. Doctors, on the other hand, leaned towards prescribing drugs alone (48%) or a combination of psychotherapy and drugs (32.5%). In severe cases, doctors predominantly advised psychotherapy coupled with prescribed drugs (44.5%).

In the realm of severe depression, ChatGPT outshone doctors yet again, advocating for treatment alignment with clinical guidelines more frequently – 100% for ChatGPT-4. A notable contrast was the 40% of doctors who exclusively recommended drug treatment, a deviation from ChatGPT's approach.

Moreover, doctors frequently proposed a blend of antidepressants, anti-anxiety medications, and sleeping pills in 67.5% of cases, while ChatGPT leaned more towards recommending antidepressants alone, with 74% for ChatGPT-3.5 and 68% for ChatGPT-4. ChatGPT-3.5 (26%) and ChatGPT-4 (32%) also suggested a combination of these medications.

Also Read: DS Group's Strategic Expansion: Prospects Of A ₹2,000 Crore Deal With Great India Place Mall

The study's key takeaway was the precision and unbiased nature of ChatGPT-4's treatment alignment with clinical guidelines. No discernible biases related to gender or socioeconomic status were detected in the ChatGPT systems, signifying their potential to enhance decision-making in primary healthcare.

In short, this research underlines the potential of AI chatbots, such as ChatGPT, to serve as valuable tools for healthcare professionals by offering evidence-based and unbiased treatment recommendations for clinical depression. This development has the potential to elevate the standard of care for patients suffering from depression and represents a significant stride in the realm of technology-assisted healthcare.

Author
No Image
Author
Arijit Dutta

You May Also Like